pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
0 catalysts
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIBBIOGEN INC.
0 catalysts
← prev
page 237 of 271
next →
131
Pain89
Neurology1
Phase 2
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
0 catalysts
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYCBICYCLE THERAPEUTICS PLC
0 catalysts
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
0 catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTLAutolus Therapeutics plc
0 catalysts
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0 catalysts
Phase 1
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
0 catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0 catalysts
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
0 catalysts
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
0 catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
0 catalysts
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
0 catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0 catalysts
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Somatostatin receptor
Camurus AB
0 catalysts
Preclinical
octreotide acetate
Octreotide Acetate (octreotide acetate)
Intracranial Hypertension
NBO Pharma LLC
0 catalysts
Marketed
octreotide acetate DR
Mycapssa (octreotide acetate)
Acromegaly
Chiasma Inc
0 catalysts
Marketed
octreotide acetate LA
Sandostatin LAR (octreotide acetate)
Diarrhea
$NVSNOVARTIS AG
0 catalysts
Phase 2
odafosfamide
odafosfamide [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
OBI Pharma Inc
0 catalysts
Phase 2
odatroltide
odatroltide [INN]
Acute Ischemic Stroke
Lumosa Therapeutics Co Ltd
0 catalysts
Phase 3
odronextamab
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD20T cell surface glycoprotein CD3
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
olafertinib
olafertinib [INN]
Non-Small Cell Lung Cancer
Checkpoint Therapeutics Inc
0 catalysts
pre_registration
olanzapine ER
olanzapine
Schizophrenia
D2-like dopamine receptor5-hydroxytryptamine receptor 2C
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Marketed
olanzapine pamoate XR
Zyprexa Relprevv (olanzapine pamoate)
Schizophrenia
CHEPLAPHARM Arzneimittel GmbH
0 catalysts
Phase 2
olaptesed pegol
olaptesed pegol [INN]
Glioblastoma Multiforme (GBM)
TME Pharma AG
0 catalysts
Phase 2
olastrocel
olastrocel [INN]
Type 1 Diabetes (Juvenile Diabetes)
$CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
0 catalysts
Phase 2
olatorepatide
olatorepatide [INN]
Obesity
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts